AI-based digital MammaPrint assay predicts recurrence risk and survival in early-stage breast cancer
AI-based digital MammaPrint assay predicts recurrence risk and survival in early-stage breast cancer
UEG 2026: Improving early detection of colorectal cancer
Using artificial intelligence to improve lung cancer screening and risk prediction
Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours
Highlights from APCCC 2026
CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer
ctDNA predicts early treatment response in HPV-associated anal cancer
Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations
EAU 2026: Updates in NMIBC
The Vanessa Moss Prize: celebrating research into cancer health disparities
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer